Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice

Journal of Experimental Therapeutics and Oncology

Volumn 2, Issue 6, 2002, Pages 337-349

  Satoh, Yuji ^a,c   Esche, Clemens ^a,b   Gambotto, Andrea ^a,b   Shurin, Galina V ^a,b   Yurkovetsky, Zoya R ^b   Robbins, Paul D ^b   Watkins, Simon C ^b   Todo, Satoru ^c   Herberman, Ronald B ^a,b   Lotze, Michael T ^a   Shurin, Michael R ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Dendritic cells; IL 12; Immunotherapy; Liver tumor

Indexed keywords

INTERLEUKIN 12; LEUKOCYTE ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ADENOCARCINOMA; ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ANIMAL; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL DIVISION; CELLULAR IMMUNITY; COLON TUMOR; COMPARATIVE STUDY; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; LIVER TUMOR; LYMPH NODE; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; PHYSIOLOGY; SPLEEN; TRANSPLANTATION; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER INCIDENCE; CANCER SURGERY; COLON ADENOCARCINOMA; COLORECTAL CANCER; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE THERAPY; IMMUNE RESPONSE; IMMUNOTHERAPY; LIVER METASTASIS; LIVER RESECTION; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; COLONIC NEOPLASMS; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-12; LIVER NEOPLASMS, EXPERIMENTAL; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 18644367888     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1359-4117.2002.01050.x     Document Type: Article

References (36)

1. Atkins MB, Robertson MJ, Gordon M, et al. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin Cancer Res 3: 409-17, 1997.
2. Bramson JL, Hitt M, Addison CL, Muller WJ, Gauldie J, Graham FL. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum Gene Ther 7: 1995-2002, 1996.
3. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178: 1223-30, 1993.
4. Caruso M, Pham-Nguyen K, Kwong YL, Xu B, Kosai KI, Finegold M, Woo SL, Chen SH. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA 93: 11302-6, 1996.
5. Chen W, Rains N, Young D, Stubbs RS. Dendritic cell-based cancer immunotherapy: Potential for treatment of colorectal cancer? J Gastroenterol Hepatol 15: 698-705, 2000.
6. Cohen J. IL-12 deaths: Explanation and a puzzle. Science 270: 908, 1995.
7. Esche C, Cai Q, Peron JM, Hunter O, Subbotin VM, Lotze MT, Shurin MR, Interleukin-12 and Flt3 ligand differentially promote dendropoiesis in vivo. Eur J Immunol 30: 2565-75, 2000a.
8. Esche C, Lokshin A, Shurin GV, Gastman BR, Rabinowich H, Watkins SC, Lotze MT, Shurin MR. Tumor's other immune targets: Dendritic cells. J Leukoc Biol 66: 336-44, 1999a.
9. Esche C, Shurin MR, Lotze MT. The use of dendritic cells for cancer vaccination. Curr Opin Mol Ther 1: 72-81, 1999b.
10. Esche C, Shurin MR, Lotze MT. IL-12. Cytokine Reference 187-201, 2000b.
11. Esche C, Shurin MR, Lotze MT. IL-12. Cytokine Reference 1503-9, 2000c.
12. Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin 49: 231-55, 1999.
13. Foon KA. Immunotherapy for colorectal cancer. Curr Oncol Rep 3: 116-26, 2001.
14. Furumoto K, Arii S, Yamasaki S, Mizumoto M, Mori A, Inoue N, Isobe N, Imamura M. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses. Int J Cancer 87: 665-72, 2000.
15. Gambotto A, Tuting T, McVey DL, Kovesdi I, Tahara H, Lotze MT, Robbins PD. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Cancer Gene Ther 6: 45-53, 1999.
16. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 51: 15-36, 2001.
17. Hewitt PM, Dwerryhouse SJ, Zhao J, Morris DL. Multiple bilobar liver metastases: Cryotherapy for residual lesions after liver resection. J Surg Oncol 67: 112-6, 1998.
18. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N, Schuler G. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184: 741-6, 1996.
19. Morse MA, Nair S, Fernandez-Casal M, et al. Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. J Clin Oncol 18: 3883-93, 2000.
20. Nastala CL, Edington HD, McKinney TG, et al. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol 153:1697-706, 1994.
21. Pirtskhalaishvili G, Shurin GV, Esche C, Cai Q, Salup RR, Bykovskaia SN, Lotze MT, Shurin MR. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br J Cancer 83: 506-13, 2000a.
22. Pirtskhalaishvili G, Shurin GV, Gambotto A, Esche C, Wahl M, Yurkovetsky ZR, Robbins PD, Shurin MR. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice. J Immunol 165: 1956-64, 2000b.
23. Radinsky R, Ellis LM. Molecular determinants in the biology of liver metastasis. Surg Oncol Clin North Am 5: 215-29, 1996.
24. Rakhmilevich AL, Turner J, Ford MJ, McCabe D, Sun WH, Sondel PM, Grota K, Yang NS. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci USA 93: 6291-6, 1996.
25. Schwaab T, Weiss JE, Schned AR, Barth RJ Jr. Dendritic cell infiltration in colon cancer. J Immunother 24: 130-7, 2001.
26. Shurin MR. Dendritic cells presenting tumor antigen. Cancer Immunol Immunother 43: 158-64, 1996.
27. Shurin MR, Esche C, Lokshin A, Lotze MT. Apoptosis in dendritic cells. In: Lotze MT, Thomson AW, eds. Dendritic Cells: Biology and Clinical Applications. San Diego: Academic Press 673-92, 1999a.
28. Shurin MR, Esche C, Peron JM, Lotze MT. Antitumor activities of IL-12 and mechanisms of action. Chem Immunol 68: 153-74, 1997a.
29. Shurin MR, Gabrilovich DI. Regulation of dendritic cell system by tumor. Cancer Res Ther Control 11: 65-78, 2001.
30. Shurin MR, Kirkwood JM, Esche C. Cytokine-based therapy for melanoma: Pre-clinical studies. Forum (Genova) 10: 204-26, 2000.
31. Shurin MR, Lu L, Kalinski P, Stewart-Akers AM, Lotze MT. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol. 21: 339-59, 1999b.
32. Shurin MR, Pandharipande PP, Zorina TD, et al. FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol. 179: 174-84, 1997b.
33. Steinman RM. Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation. Mt Sinai J Med 68: 106-66, 2001.
34. Tahara H, Zitvogel L, Storkus WJ, et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J Immunol 154: 6466-74, 1995.
35. Yamashita YI, Shimada M, Hasegawa H, et al. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res 61: 1005-12, 2001.
36. Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol 155: 1393-403, 1995.